SeqOnce Biosciences
Private Company
Total funding raised: $3.2M
Overview
Bandit Bio (operating under the SeqOnce brand) is a private, commercial-stage company providing research-use molecular biology tools, including multiplex qPCR kits and RhinoSeq NGS library prep kits. Founded as a spin-out from the University of Southern California, the company leverages expertise in molecular biology and technology development to deliver rapid, informative nucleic acid testing solutions. It operates as a portfolio company of G3 Genomics and targets researchers in genomics and pathogen detection with its streamlined protocols and multi-platform support. The company is revenue-generating, selling its kits and providing technical support to the global research community.
Technology Platform
Focus on rapid multiplex qPCR assays and simplified NGS library prep kits designed for use on open-source, third-party laboratory instruments. The platform emphasizes workflow speed, higher throughput, and broad instrument compatibility.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Bandit Bio competes in the crowded life science research tools market against giants like Thermo Fisher, Qiagen, and Bio-Rad in qPCR, and Illumina and others in NGS library prep. Its differentiation lies in its focus on rapid, simple, open-platform solutions, carving out a niche among cost-conscious researchers seeking high-performance alternatives to vendor-locked systems.